MUC17 and endometrial endometrioid adenocarcinoma: Uterine corpus endometrioid endometrial adenocarcinoma (UEC) appears to acquire more mutations in multiple mucins, including MUC5B and MUC17, which becomes very prominent in stage III (Figures 1A, 1B, and Supplementary Dataset 1).